{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:33:23Z","timestamp":1790685203024,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>1p\/19q-codeleted anaplastic gliomas have variable clinical behavior. We have recently shown that the common 9p21.3 allelic loss is an independent prognostic factor in this tumor type. The aim of this study is to identify less frequent genomic copy number variations (CNVs) with clinical importance that may shed light on molecular oncogenesis of this tumor type.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>A cohort of 197 patients with anaplastic oligodendroglioma was collected as part of the French POLA network. Clinical, pathological, and molecular information was recorded. CNV analysis was performed using single-nucleotide polymorphism arrays. Computational biology and feature selection based on the random forests method were used to identify CNV events associated with overall survival and other clinical-pathological variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Recurrent chromosomal events were identified in chromosomes 4, 9, and 11. Forty-six focal amplification events and 22 focal deletion events were identified. Twenty-four focal CNV areas were associated with survival, and five of them were significantly associated with survival after multivariable analysis. Nine out of 24 CNV events were validated using an external cohort of The Cancer Genome Atlas. Five of the validated events contain a cancer-related gene or microRNA: CDKN2A deletion, SS18L1 amplification, RHOA\/MIR191 copy-neutral loss of heterozygosity, FGFR3 amplification, and ARNT amplification. The CNV profile contributes to better survival prediction compared with clinical-based risk assessment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Several recurrent CNV events, detected in anaplastic oligodendroglioma, enable better survival prediction. More importantly, they help in identifying potential genes for understanding oncogenesis and for personalized therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications for Practice<\/jats:title>\n                  <jats:p>Genomic analysis of 197 anaplastic oligodendroglioma tumors reveals recurrent somatic copy number variation areas that may help in understanding oncogenesis and target identification for precision medicine. A machine learning multivariable model built using this genomic information enables better survival prediction.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2017-0495","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T12:15:40Z","timestamp":1531829740000},"page":"1500-1510","source":"Crossref","is-referenced-by-count":11,"title":["Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma"],"prefix":"10.1093","volume":"23","author":[{"given":"Shai","family":"Rosenberg","sequence":"first","affiliation":[{"name":"Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, INSERM U1127, CNRS UMR7225, Paris, France"},{"name":"Gaffin Center for Neuro-Oncology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Ducray","sequence":"additional","affiliation":[{"name":"Service de Neuro-Oncologie, H\u00f4pital Neurologique, Hospices Civils de Lyon, Lyon, France"},{"name":"Department of Cancer Cell Plasticity, Cancer Research Centre of Lyon, INSERM U1052, CNRS UMR5286, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agusti","family":"Alentorn","sequence":"additional","affiliation":[{"name":"Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, INSERM U1127, CNRS UMR7225, Paris, France"},{"name":"Service de Neurologie 2-Mazarin, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re - Charles Foix, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dehais","sequence":"additional","affiliation":[{"name":"Service de Neurologie 2-Mazarin, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re - Charles Foix, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Elarouci","sequence":"additional","affiliation":[{"name":"Programme cartes d'identite des tumeurs, Ligue nationale contre le cancer, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Kamoun","sequence":"additional","affiliation":[{"name":"Programme cartes d'identite des tumeurs, Ligue nationale contre le cancer, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Marie","sequence":"additional","affiliation":[{"name":"Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, INSERM U1127, CNRS UMR7225, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Tanguy","sequence":"additional","affiliation":[{"name":"Service de Biostatistiques, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re - Charles Foix, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"De Reynies","sequence":"additional","affiliation":[{"name":"Programme cartes d'identite des tumeurs, Ligue nationale contre le cancer, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Mokhtari","sequence":"additional","affiliation":[{"name":"Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, INSERM U1127, CNRS UMR7225, Paris, France"},{"name":"Laboratoire de Neuropathologie Raymond Escourolle, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Figarella-Branger","sequence":"additional","affiliation":[{"name":"Institut de Neurophysiopathologie, team GlioME, Faculte de Medecine, Universite d' Aix-Marseille, Marseille, France"},{"name":"Service d'Anatomie Pathologique et de Neuropathologie, H\u00f4pital de la Timone, AP-HM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Delattre","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM U1127, CNRS UMR7225, Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Idbaih","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM U1127, CNRS UMR7225, Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"POLA Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"key":"2021122511254498200_onco12579-bib-0001","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: A \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"2021122511254498200_onco12579-bib-0002","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Cancer Genome Atlas Research Network","year":"2015","journal-title":"N Engl J Med"},{"key":"2021122511254498200_onco12579-bib-0003","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng.3273","article-title":"Mutational landscape and clonal architecture in grade II and III gliomas","volume":"47","author":"Suzuki","year":"2015","journal-title":"Nat Genet"},{"key":"2021122511254498200_onco12579-bib-0004","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"key":"2021122511254498200_onco12579-bib-0005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2021122511254498200_onco12579-bib-0006","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ng.2762","article-title":"Emerging landscape of oncogenic signatures across human cancers","volume":"45","author":"Ciriello","year":"2013","journal-title":"Nat Genet"},{"key":"2021122511254498200_onco12579-bib-0007","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nbt.2940","article-title":"Assessing the clinical utility of cancer genomic and proteomic data across tumor types","volume":"32","author":"Yuan","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2021122511254498200_onco12579-bib-0008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"2021122511254498200_onco12579-bib-0009","doi-asserted-by":"crossref","first-page":"e45950","DOI":"10.1371\/journal.pone.0045950","article-title":"SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas","volume":"7","author":"Idbaih","year":"2012","journal-title":"PloS One"},{"key":"2021122511254498200_onco12579-bib-0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/1471-2105-9-409","article-title":"Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios","volume":"9","author":"Staaf","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"2021122511254498200_onco12579-bib-0011","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1093\/nar\/gkr014","article-title":"GPHMM: An integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays","volume":"39","author":"Li","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2021122511254498200_onco12579-bib-0012","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"2021122511254498200_onco12579-bib-0013","doi-asserted-by":"crossref","first-page":"D986","DOI":"10.1093\/nar\/gkt958","article-title":"The Database of Genomic Variants: A curated collection of structural variation in the human genome","volume":"42","author":"MacDonald","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2021122511254498200_onco12579-bib-0014","volume-title":"Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model","year":"2000"},{"key":"2021122511254498200_onco12579-bib-0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann Appl Stat"},{"key":"2021122511254498200_onco12579-bib-0016","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"key":"2021122511254498200_onco12579-bib-0017","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/bioinformatics\/btr511","article-title":"survcomp: An R\/Bioconductor package for performance assessment and comparison of survival models","volume":"27","author":"Schr\u00f6der","year":"2001","journal-title":"Bioinformatics"},{"key":"2021122511254498200_onco12579-bib-0018","doi-asserted-by":"crossref","first-page":"e1003118","DOI":"10.1371\/journal.pcbi.1003118","article-title":"Software for computing and annotating genomic ranges","volume":"9","author":"Lawrence","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"2021122511254498200_onco12579-bib-0019","first-page":"401","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer","volume":"2","author":"Cerami","year":"2012","journal-title":"Discov"},{"key":"2021122511254498200_onco12579-bib-0020","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: Exploring the world's knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2021122511254498200_onco12579-bib-0021","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/bioinformatics\/btu155","article-title":"OncomiRDB: A database for the experimentally verified oncogenic and tumor-suppressive microRNAs","volume":"30","author":"Wang","year":"2014","journal-title":"Bioinformatics"},{"key":"2021122511254498200_onco12579-bib-0022","first-page":"475","article-title":"FGFR-TACC gene fusions in human glioma","volume":"19","author":"Lasorella","year":"2017","journal-title":"Neuro Oncol"},{"key":"2021122511254498200_onco12579-bib-0023","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ccell.2015.02.007","article-title":"In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities","volume":"27","author":"Rubio-Perez","year":"2015","journal-title":"Cancer Cell"},{"key":"2021122511254498200_onco12579-bib-0024","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/neuonc\/nou047","article-title":"Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p\/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations","volume":"16","author":"Figarella-Branger","year":"2014","journal-title":"Neuro Oncol"},{"key":"2021122511254498200_onco12579-bib-0025","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/neuonc\/now025","article-title":"Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling","volume":"18","author":"Figarella-Branger","year":"2016","journal-title":"Neuro Oncol"},{"key":"2021122511254498200_onco12579-bib-0026","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1080\/15384101.2015.1068482","article-title":"Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells","volume":"14","author":"Kuznetsova","year":"2015","journal-title":"Cell Cycle"},{"key":"2021122511254498200_onco12579-bib-0027","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/WNL.0000000000002014","article-title":"POLA Network. Allelic loss of 9p21.3 is a prognostic factor in 1p\/19q codeleted anaplastic gliomas","volume":"85","author":"Alentorn","year":"2015","journal-title":"Neurology"},{"key":"2021122511254498200_onco12579-bib-0028","doi-asserted-by":"crossref","first-page":"11263","DOI":"10.1038\/ncomms11263","article-title":"POLA Network. Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p\/19q co-deleted gliomas","volume":"7","author":"Kamoun","year":"2016","journal-title":"Nat Commun"},{"key":"2021122511254498200_onco12579-bib-0029","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nature Biotechnol"},{"key":"2021122511254498200_onco12579-bib-0030","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nature Genetics"},{"key":"2021122511254498200_onco12579-bib-0031","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.ajpath.2016.02.024","article-title":"Cytoplasmic cyclin E and phospho-cyclin-dependent kinase 2 are biomarkers of aggressive breast cancer","volume":"186","author":"Karakas","year":"2016","journal-title":"Am J Pathol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2017-0495","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2017-0495","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/23\/12\/1500\/41915173\/oncolo_23_12_1500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/23\/12\/1500\/41915173\/oncolo_23_12_1500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T06:29:32Z","timestamp":1640413772000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/23\/12\/1500\/6439800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,7,17]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2017-0495","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,1]]},"published":{"date-parts":[[2018,7,17]]}}}